Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leopold I: BAY81-8973 in Severe Hemophilia A
NCT01029340Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2009
- Primary completion
- Jun 2012
- Countries
- 22
01
Overview
A Phase 3 trial of damoctocog alfa pegol in hemophilia A, sponsored by Bayer. Started Dec 2009; status: completed.
02
Drugs
damoctocog alfa pegol
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT01029340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01029340.